aRWD: real-world data from cohort or registry studies (electronic health records, insurance-claims databases), bSRS: adverse drug reaction evidence from case reports and spontaneous-reporting systems, such as the Food and Drug Administration (FDA) Adverse Event Reporting System (FAERS) and World Health Organization (WHO) VigiBase
Melanotan-2 is used in controlled laboratory settings to help researchers evaluate targeted biological pathways
Studies suggest that overall adherence is crucial to sustained weight loss on GLP-1s
No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred
Side effects and safety profile The side effect profile of CagriSema largely reflects what is already known from its two component drugs, with gastrointestinal effects being the most commonly reported
Our providers start with a low dose and monitor your response closely to keep you comfortable and on track